These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38355957)

  • 1. Expanding the genetic and phenotypic spectrum of congenital myasthenic syndrome: new homozygous VAMP1 splicing variants in 2 novel individuals.
    Cotrina-Vinagre FJ; Rodríguez-García ME; Del Pozo-Filíu L; Hernández-Laín A; Arteche-López A; Morte B; Sevilla M; Pérez-Jurado LA; Quijada-Fraile P; Camacho A; Martínez-Azorín F
    J Hum Genet; 2024 May; 69(5):187-196. PubMed ID: 38355957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyrostigmine therapy in a patient with VAMP1-related congenital myasthenic syndrome.
    Al-Muhaizea MA; AlQuait L; AlRasheed A; AlHarbi S; Albader AA; AlMass R; Albakheet A; Alhumaidan A; AlRasheed MM; Colak D; Kaya N
    Neuromuscul Disord; 2020 Jul; 30(7):611-615. PubMed ID: 32616363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homozygous mutations in VAMP1 cause a presynaptic congenital myasthenic syndrome.
    Salpietro V; Lin W; Delle Vedove A; Storbeck M; Liu Y; Efthymiou S; Manole A; Wiethoff S; Ye Q; Saggar A; McElreavey K; Krishnakumar SS; ; Pitt M; Bello OD; Rothman JE; Basel-Vanagaite L; Hubshman MW; Aharoni S; Manzur AY; Wirth B; Houlden H
    Ann Neurol; 2017 Apr; 81(4):597-603. PubMed ID: 28253535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advancing the Understanding of Vesicle-Associated Membrane Protein 1-Related Congenital Myasthenic Syndrome: Phenotypic Insights, Favorable Response to 3,4-Diaminopyridine, and Clinical Characterization of Five New Cases.
    Natera-de Benito D; Pugliese A; Polavarapu K; Guergueltcheva V; Tournev I; Todorova A; Afonso Ribeiro J; Fernández-Mayoralas DM; Ortez C; Martorell L; Estévez-Arias B; Matalonga L; Laurie S; Jou C; Lau J; Thompson R; Shen X; Engel AG; Nascimento A; Lochmüller H; Selcen D
    Pediatr Neurol; 2024 Aug; 157():5-13. PubMed ID: 38833907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recessive VAMP1 mutations associated with severe congenital myasthenic syndromes - A recognizable clinical phenotype.
    Polavarapu K; Vengalil S; Preethish-Kumar V; Arunachal G; Nashi S; Mohan D; Chawla T; Bardhan M; Nandeesh B; Gupta P; Gowda VK; Lochmüller H; Nalini A
    Eur J Paediatr Neurol; 2021 Mar; 31():54-60. PubMed ID: 33631708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VAMP1-Related Congenital Myasthenic Syndrome: A Case Report and Literature Review.
    Yıldırım M; Yarenci GB; Genç MB; Uçar Çİ; Bayav S; Tekin MN; Bektaş Ö; Teber S
    Neuropediatrics; 2024 Jun; 55(3):200-204. PubMed ID: 38531369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VAMP1 mutation causes dominant hereditary spastic ataxia in Newfoundland families.
    Bourassa CV; Meijer IA; Merner ND; Grewal KK; Stefanelli MG; Hodgkinson K; Ives EJ; Pryse-Phillips W; Jog M; Boycott K; Grimes DA; Goobie S; Leckey R; Dion PA; Rouleau GA
    Am J Hum Genet; 2012 Sep; 91(3):548-52. PubMed ID: 22958904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biallelic loss of function variants in SYT2 cause a treatable congenital onset presynaptic myasthenic syndrome.
    Donkervoort S; Mohassel P; Laugwitz L; Zaki MS; Kamsteeg EJ; Maroofian R; Chao KR; Verschuuren-Bemelmans CC; Horber V; Fock AJM; McCarty RM; Jain MS; Biancavilla V; McMacken G; Nalls M; Voermans NC; Elbendary HM; Snyder M; Cai C; Lehky TJ; Stanley V; Iannaccone ST; Foley AR; Lochmüller H; Gleeson J; Houlden H; Haack TB; Horvath R; Bönnemann CG
    Am J Med Genet A; 2020 Oct; 182(10):2272-2283. PubMed ID: 32776697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to Spot Congenital Myasthenic Syndromes Resembling the Lambert-Eaton Myasthenic Syndrome? A Brief Review of Clinical, Electrophysiological, and Genetics Features.
    Lorenzoni PJ; Scola RH; Kay CSK; Werneck LC; Horvath R; Lochmüller H
    Neuromolecular Med; 2018 Jun; 20(2):205-214. PubMed ID: 29696584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First maternal uniparental disomy for chromosome 2 with PREPL novel frameshift mutation of congenital myasthenic syndrome 22 in an infant.
    Zhang P; Wu B; Lu Y; Ni Q; Liu R; Zhou W; Wang H
    Mol Genet Genomic Med; 2020 Mar; 8(3):e1144. PubMed ID: 31985178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A common mutation (epsilon1267delG) in congenital myasthenic patients of Gypsy ethnic origin.
    Abicht A; Stucka R; Karcagi V; Herczegfalvi A; Horváth R; Mortier W; Schara U; Ramaekers V; Jost W; Brunner J; Janssen G; Seidel U; Schlotter B; Müller-Felber W; Pongratz D; Rüdel R; Lochmüller H
    Neurology; 1999 Oct; 53(7):1564-9. PubMed ID: 10534268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding the spectrum of LAMB2: Pierson syndrome associated with neuromuscular junction disorder in two patients.
    Paiz F; Alawneh I; Nigro E; Gonorazky HD
    Neuromuscul Disord; 2024 Jun; 39():30-32. PubMed ID: 38723581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and molecular analysis of a novel COLQ missense mutation causing congenital myasthenic syndrome in a Syrian family.
    Matlik HN; Milhem RM; Saadeldin IY; Al-Jaibeji HS; Al-Gazali L; Ali BR
    Pediatr Neurol; 2014 Jul; 51(1):165-9. PubMed ID: 24938146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical spectrum of the congenital myasthenic syndrome resulting from COL13A1 mutations.
    Rodríguez Cruz PM; Cossins J; Estephan EP; Munell F; Selby K; Hirano M; Maroofin R; Mehrjardi MYV; Chow G; Carr A; Manzur A; Robb S; Munot P; Wei Liu W; Banka S; Fraser H; De Goede C; Zanoteli E; Conti Reed U; Sage A; Gratacos M; Macaya A; Dusl M; Senderek J; Töpf A; Hofer M; Knight R; Ramdas S; Jayawant S; Lochmüller H; Palace J; Beeson D
    Brain; 2019 Jun; 142(6):1547-1560. PubMed ID: 31081514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital Myasthenic Syndrome Type 19 Is Caused by Mutations in COL13A1, Encoding the Atypical Non-fibrillar Collagen Type XIII α1 Chain.
    Logan CV; Cossins J; Rodríguez Cruz PM; Parry DA; Maxwell S; Martínez-Martínez P; Riepsaame J; Abdelhamed ZA; Lake AV; Moran M; Robb S; Chow G; Sewry C; Hopkins PM; Sheridan E; Jayawant S; Palace J; Johnson CA; Beeson D
    Am J Hum Genet; 2015 Dec; 97(6):878-85. PubMed ID: 26626625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agrin mutations lead to a congenital myasthenic syndrome with distal muscle weakness and atrophy.
    Nicole S; Chaouch A; Torbergsen T; Bauché S; de Bruyckere E; Fontenille MJ; Horn MA; van Ghelue M; Løseth S; Issop Y; Cox D; Müller JS; Evangelista T; Stålberg E; Ioos C; Barois A; Brochier G; Sternberg D; Fournier E; Hantaï D; Abicht A; Dusl M; Laval SH; Griffin H; Eymard B; Lochmüller H
    Brain; 2014 Sep; 137(Pt 9):2429-43. PubMed ID: 24951643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The spectrum of mutations that underlie the neuromuscular junction synaptopathy in DOK7 congenital myasthenic syndrome.
    Cossins J; Liu WW; Belaya K; Maxwell S; Oldridge M; Lester T; Robb S; Beeson D
    Hum Mol Genet; 2012 Sep; 21(17):3765-75. PubMed ID: 22661499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Neuromuscular Junction and Wide Heterogeneity of Congenital Myasthenic Syndromes.
    Rodríguez Cruz PM; Palace J; Beeson D
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29874875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a novel Vamp1 splice variant in the cochlear nucleus.
    Friedland DR; Eernisse R; Popper P
    Hear Res; 2008 Sep; 243(1-2):105-12. PubMed ID: 18655825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel copy number variation of COLQ gene in a Moroccan patient with congenital myasthenic syndrome: a case report and review of the literature.
    El Kadiri Y; Ratbi I; Sefiani A; Lyahyai J
    BMC Neurol; 2022 Aug; 22(1):292. PubMed ID: 35932018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.